Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GPR120 Agonist 3 (GPR120-IN-1) 是一种有效的、选择性的 Gpr120激动剂,logEC50为 −7.62。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 347 | 现货 | ||
2 mg | ¥ 490 | 现货 | ||
5 mg | ¥ 828 | 现货 | ||
10 mg | ¥ 1,490 | 现货 | ||
25 mg | ¥ 2,880 | 现货 | ||
50 mg | ¥ 4,130 | 现货 | ||
100 mg | ¥ 6,220 | 现货 | ||
500 mg | ¥ 12,300 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 892 | 现货 |
产品描述 | GPR120 Agonist 3 (GPR120-IN-1) is a selective agonist of Gpr120 ( logEC50: -7.62). |
靶点活性 | GPR120:−7.62 (logEC50) |
体外活性 | GPR120-IN-1 causes a concentration-dependent response to recruiting β-arrestin-2 in both human and mouse Gpr120 expressing cells(EC50s: ~0.35 μM). GPR120-IN-1 produces concentration-dependent increases in IP3 production from both human and mouse Gpr120 expressing cells. GPR120-IN-1 strongly and comparably inhibits LPS-induced phosphorylation of Ikkβ, Tak1, and Jnk and blocked IκB degradation. |
体内活性 | GPR120-IN-1 treatment has beneficial effects on hepatic lipid metabolism. It causes decreased liver triglycerides, decreased hepatic steatosis, and DAGs, as well as decreased saturated free fatty acid content. GPR120-IN-1 causes improved insulin sensitivity with increased glucose infusion rates. It also enhanced the insulin stimulated-glucose disposal rate. Only in WT mice, along with a marked increase in the ability of insulin to suppress hepatic glucose production. |
别名 | GPR120-IN-1 |
分子量 | 405.84 |
分子式 | C19H23ClF3NO3 |
CAS No. | 1599477-75-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (123.20 mM)
H2O: < 0.1 mg/mL (insoluble), Sonication and heating to 60℃ are recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.464 mL | 12.3201 mL | 24.6403 mL | 61.6006 mL |
5 mM | 0.4928 mL | 2.464 mL | 4.9281 mL | 12.3201 mL | |
10 mM | 0.2464 mL | 1.232 mL | 2.464 mL | 6.1601 mL | |
20 mM | 0.1232 mL | 0.616 mL | 1.232 mL | 3.08 mL | |
50 mM | 0.0493 mL | 0.2464 mL | 0.4928 mL | 1.232 mL | |
100 mM | 0.0246 mL | 0.1232 mL | 0.2464 mL | 0.616 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
GPR120 Agonist 3 1599477-75-4 Endocrinology/Hormones GPCR/G Protein GPR FFAR GPR120-IN-1 Free Fatty Acid Receptor inhibit Inhibitor GPR-120 Agonist 3 inhibitor